Literature DB >> 6781338

Incidence and severity of viral hepatitis in pregnancy.

M S Khuroo, M R Teli, S Skidmore, M A Sofi, M I Khuroo.   

Abstract

A prospective field study was carried out during an epidemic of non-A non-B hepatitis for determining the incidence and severity of hepatitis in pregnant women, nonpregnant women of child bearing age and men (15 to 45 years old). In 36 (17.3 percent) of 208 pregnant women viral hepatitis developed, as compared to 71 (2.1 percent) of 3,350 nonpregnant women and 107 (2.8 percent) of 3,822 men. The incidence of disease in pregnant women was higher than in the two control groups. The incidence of viral hepatitis in the first, second and third trimesters was 8.8 percent, 19.4 percent, and 18.6 percent, respectively. The incidence in all three trimesters was higher, when compared to that in nonpregnant women. In eight pregnant women (22.2 percent) with viral hepatitis, fulminant hepatic failure developed, as compared to its occurrence in three men (2.8 percent) and in no nonpregnant women. This significantly increased incidence of fulminant hepatitis in pregnancy was indicative of a greater severity of hepatitis during pregnancy. Increased susceptibility to fulminant hepatitis was observed exclusively in the last trimester. Nonfulminant viral hepatitis did not influence the course of pregnancy or fetal well-being. Fetal loss in fatal fulminant hepatitis was a consequence of maternal death and could not be ascribed to direct effect on the fetus or pregnancy.

Entities:  

Keywords:  Asia; Biology; Data Collection; Developing Countries; Diseases; Health; Hepatic Effects; Incidence; India; Maternal Nutrition; Measurement; Nutrition; Physiology; Pregnancy; Pregnancy Outcomes; Prospective Studies; Reproduction; Research Methodology; Southern Asia; Studies; Viral Diseases

Mesh:

Year:  1981        PMID: 6781338     DOI: 10.1016/0002-9343(81)90758-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  116 in total

1.  Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.

Authors:  C Yu; R E Engle; J P Bryan; S U Emerson; R H Purcell
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

3.  Hepatitis E infection.

Authors:  Vincent C Kuo
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-04

4.  Hepatitis E: are psychiatric patients on special risk?

Authors:  Claudia Reinheimer; Regina Allwinn; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2011-10-18       Impact factor: 3.402

Review 5.  Small Animal Models of Hepatitis E Virus Infection.

Authors:  Tian-Cheng Li; Takaji Wakita
Journal:  Cold Spring Harb Perspect Med       Date:  2019-08-01       Impact factor: 6.915

Review 6.  Hepatology.

Authors:  P M Harrison; J Y Lau; R Williams
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

Review 7.  Viral hepatitis.

Authors:  J Y Lau; G J Alexander; A Alberti
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

8.  Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.

Authors:  Bangari Haldipur; Prudhvi Lal Bhukya; Vidya Arankalle; Kavita Lole
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

9.  Factors influencing occurrence of postpartum haemorrhage in pregnant women with hepatitis E infection and deranged coagulation profile.

Authors:  Manju Puri; Sharda Patra; Preeti Singh; Nidhi Malhotra; Shubha Sagar Trivedi; Sunita Sharma; Ashish Kumar; Shiv Kumar Sarin
Journal:  Obstet Med       Date:  2011-08-23

10.  Characterization of a strain of infectious hepatitis E virus isolated from sewage in an area where hepatitis E is not endemic.

Authors:  S Pina; J Jofre; S U Emerson; R H Purcell; R Girones
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.